| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SKWD | Common Stock | Sale | $215,233 | -4,347 | -26% | $49.51 | 12,508 | 02 Jan 2025 | Direct | F1, F2, F3 |
| transaction | SKWD | Common Stock | Sale | $26,350 | -551 | -4.4% | $47.82 | 11,957 | 03 Jan 2025 | Direct | F1, F2 |
| transaction | SKWD | Common Stock | Sale | $32,309 | -678 | -5.7% | $47.65 | 11,279 | 03 Jan 2025 | Direct | F2, F4, F5 |
| transaction | SKWD | Common Stock | Sale | $20,864 | -444 | -3.9% | $46.99 | 10,835 | 06 Jan 2025 | Direct | F2, F4, F5 |
| transaction | SKWD | Common Stock | Sale | $21,792 | -464 | -4.3% | $46.97 | 10,371 | 06 Jan 2025 | Direct | F1, F2 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.53 to $50.63, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| F3 | The number of securities reported reflects the May 31, 2024 acquisition of 381 shares and the December 1, 2024 acquisition of 334 shares of the Company's common stock pursuant to the Skyward Specialty Insurance Group, Inc. 2022 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase periods of December 1, 2023 through May 31, 2024, and June 1, 2024 through November 30, 2024, respectively. |
| F4 | On January 1, 2022, the Reporting Person was granted a Restricted Stock Award in the amount of 2,532 shares. Each share is equivalent to one share of the Company's common stock. This award fully vested on January 1, 2025. Sales transacted to cover taxes and fees incurred by vesting event. |
| F5 | The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024. |